Na Wang

机构：Nanchang University, First Affiliated Hospital of Nanchang University · ORCID：0009-0005-0992-9312

发表论文 38 篇 · 总被引 507 次 · h-index 10

代表论文

• Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-κB and MAPK pathways via GLP-1R (2020 · Biomedicine & Pharmacotherapy · 被引 67)
• Identification of natural xanthine oxidase inhibitors: Virtual screening, anti-xanthine oxidase activity, and interaction mechanism (2024 · International Journal of Biological Macromolecules · 被引 37)
• Tannin-coated PVA/PVP/PEI nanofibrous membrane as a highly effective adsorbent and detoxifier for Cr(VI) contamination in water (2022 · Separation and Purification Technology · 被引 37)
• Data mining-guided alleviation of hyperuricemia by Paeonia veitchii Lynch through inhibition of xanthine oxidase and regulation of renal urate transporters (2023 · Phytomedicine · 被引 30)
• Antibiofilm activity of 3,3'-diindolylmethane on Staphylococcus aureus and its disinfection on common food-contact surfaces (2022 · Food Science and Human Wellness · 被引 18)
• Efficacy of transumbilical laparoendoscopic single-site surgery versus multi-port laparoscopic surgery for endometrial cancer: a retrospective comparison study (2023 · Frontiers in Oncology · 被引 12)